About AEYE Health
AEYE Health is a digital health company founded in 2019 in New York City that develops AI-based autonomous diagnostic screening solutions for ocular and systemic diseases using retinal imaging. The company's flagship product, AEYE-DS, is the only FDA-cleared solution offering instant AI diabetic retinopathy diagnosis with both handheld and tabletop cameras, requiring just one image per eye and delivering on-the-spot diagnostic reports in one minute without physician interpretation needed. The solution is CPT 92229 reimbursable and helps close HEDIS gaps. AEYE Health's technology platform enables screening for a broad range of diseases beyond diabetic retinopathy, including glaucoma, age-related macular degeneration (AMD), diabetic macular edema (DME), and systemic conditions like cardiovascular disease, hypertension, and dementia. Their Aurora AEYE product is the first and only FDA-cleared AI-powered diabetic retinopathy solution for portable cameras, achieving 92-93% sensitivity and 89-94% specificity with over 99% success rate. The company's mission is to make screening for ocular diseases more accessible and help prevent blindness, particularly in underserved communities. By enabling primary care physicians to conduct point-of-care screening, AEYE Health replaces the traditional specialist referral process, addressing the diabetic retinopathy care gap where less than 50% of US patients with diabetes adhere to annual eye exams. The company serves primary care practices, endocrinologists, and teleretinal screening services across the United States.
Mission & Story
Mission
We're Building a Technology Platform to Enable Screening For a Broad Range of Diseases
Founding Story
AEYE Health's founding members recognized the immense need to make screening for ocular diseases more accessible and identified the opportunity to address this need using AI technology. They embarked on a journey with the mission to help prevent blindness. Combining their artificial intelligence expertise with their passion for healthcare, they developed an autonomous AI-based diagnostic screening solution for retinal imaging.
Clinical Focus
Medical conditions and clinical areas addressed by AEYE Health.
Who It Serves
Milestones & Awards
Recent Milestones
FDA clearance for Aurora AEYE as first and only AI-powered diabetic retinopathy solution for portable camera. Described as 'fastest-growing diabetic retinopathy screening solution in the US'. Participation in major conferences including ADA 2026, ACD 2026, and FMX 2026.
Awards & Recognition
First and only FDA-cleared AI-powered diabetic retinopathy solution for portable camera. Best-in-class accuracy claims for diabetic retinopathy, glaucoma, and AMD detection.
Key Partnerships
Social & Media
Latest Updates
Defining the Standard: AEYE-DS Recognized in the ADA 2026 Standard of Care
How CPT 92229 turns DR screening into a revenue line
Why “Come Back Later” Doesn’t Belong in Preventive Eye Screening in 2026
Same image, different future: How AI screening outpaces Teleretina on speed, cost, and scale
How rural health organizations can pursue RHTP funding for AI Diabetic Retinopathy screening
Company Details
- Founded
- 2019
- Headquarters
- New York, NY, USA
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingOfficial Sources
Similar Companies in this Market
View all 189 →
A2z Radiology Ai
AI platform that triages urgent abdomen-pelvis CT findings and prioritizes flagged studies in radiology worklists.
Adas3D Medical S.L
11-50 employees
Adas3D Medical develops medical imaging software that extracts key clinical information from cardiac MRI and CT scans for electrophysiologists. The software helps plan, guide, and monitor catheter ablation procedures by visualizing and quantifying fibrotic tissue in the heart.
Agfa HealthCare N.V.
AGFA HealthCare provides enterprise imaging platforms that unify medical imaging across specialties. The company delivers PACS, vendor neutral archives, AI-powered workflow orchestration, and cloud-based imaging solutions to hospitals and healthcare systems worldwide.
AI4MedImaging Medical Solutions
AI4MedImaging provides AI-powered medical imaging solutions distributed through aycan Medical Systems in the Americas. Their flagship product, AI4CMR, is software as a medical device (SaMD) that automates the interpretation of cardiac magnetic resonance imaging using artificial intelligence.
Aidence
Aidence, now part of DeepHealth, develops AI-powered clinical applications for radiology and medical imaging. The company specializes in lung nodule detection, classification, and patient management solutions that empower radiologists and physicians in interpreting medical images.
Aidoc
growth · 350 employees
Aidoc empowers health systems to improve patient outcomes and operations with enterprise-grade healthcare AI.
Aikenist Technologies Pvt Ltd
21-100 employees
Aikenist Technologies is a MedTech company specializing in advanced AI-driven solutions for radiology imaging. Their offerings include an FDA-approved AI PACS and RIS with integrated viewer, appointment scheduling, billing modules, and AI tools for stroke, oncology, and neuro detection.
AIQ Global
1-50 employees
AIQ Solutions develops FDA-cleared clinical software that analyzes serial radiographic images to quantify lesion-level changes over time, supporting oncologist decision-making in complex disease management, particularly late-stage cancer care.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.